Daily Archives: July 19, 2023

Self-measured blood pressure telemonitoring programs: a pragmatic how-to guide

19 Jul, 2023 | 14:33h | UTC

Self-Measured Blood Pressure Telemonitoring Programs: A Pragmatic How-to Guide – American Journal of Hypertension

 

---

ASCO Guideline | Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy

19 Jul, 2023 | 14:31h | UTC

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update – Journal of Clinical Oncology

 

---

Changes to breast structure and function across a woman’s lifespan: implications for managing and modeling female breast injuries

19 Jul, 2023 | 14:29h | UTC

Changes to breast structure and function across a woman’s lifespan: Implications for managing and modeling female breast injuries – Clinical Biomechanics

Commentary: Breast injuries are common for female athletes. Here’s why better awareness and reporting are needed – The Conversation

 

---

Survey Study | ChatGPT’s performance in simulated patient-provider interactions

19 Jul, 2023 | 14:28h | UTC

Putting ChatGPT’s Medical Advice to the (Turing) Test: Survey Study – JMIR Medical Education

News Release: ChatGPT’s responses to healthcare-related queries ‘nearly indistinguishable’ from those provided by humans – NYU Tandon School of Engineering

Related: ChatGPT’s responses to patient questions rated higher for quality and empathy than physicians

 

---

RCT | Solanezumab fails to slow cognitive decline in preclinical Alzheimer’s disease

19 Jul, 2023 | 14:26h | UTC

Trial of Solanezumab in Preclinical Alzheimer’s Disease – New England Journal of Medicine (link to abstract – $ for full-text)

Related:

RCT | Donanemab slows early symptomatic Alzheimer’s progression, but raises serious safety concerns

RCT | Lecanemab slows cognitive decline in early Alzheimer’s disease but raises safety concerns

 

Commentary on Twitter

Original Article: Trial of Solanezumab in Preclinical Alzheimer’s Disease (A4 trial) https://t.co/lCXsVoiP8i #AAIC23 pic.twitter.com/e8DplR27yd

— NEJM (@NEJM) July 18, 2023

 

---

FDA approves first nonprescription daily oral contraceptive

19 Jul, 2023 | 14:25h | UTC

FDA Approves First Nonprescription Daily Oral Contraceptive – U.S. Food & Drug Administration

Commentary: FDA approves first daily over-the-counter birth control pill, Opill – a pharmacist and public health expert explain this new era in contraception – The Conversation

 

---

Systematic Review | An evidence-base for the implementation of hospital-based palliative care programs in routine cancer practice

19 Jul, 2023 | 14:23h | UTC

An evidence-base for the implementation of hospital-based palliative care programs in routine cancer practice: A systematic review – Palliative Medicine

 

---

Podcast | Hematuria pearls

19 Jul, 2023 | 14:19h | UTC

#404 Hematuria with Dr. Derek Fine – The Curbsiders

 

---

Large bowel obstruction | ED presentation, evaluation, and management

19 Jul, 2023 | 14:17h | UTC

Large bowel obstruction: ED presentation, evaluation, and management – emDocs

 

---

M-A | Population-level smoke-free legislation tied to better cardiovascular, respiratory, birth outcomes

19 Jul, 2023 | 14:13h | UTC

Evaluation of Population-Level Tobacco Control Interventions and Health Outcomes: A Systematic Review and Meta-Analysis – JAMA Network Open

Commentary: Smoke-Free Legislation Linked to Drop in Adverse Health Outcomes – HealthDay

 

---